Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R BINOL. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101781197B reveals a high-yield route for chiral binaphthyl dicarboxylic acid. Achieve >99% optical purity without chromatography for cost-effective supply.
Novel metallic sodium reduction method for cyclopropyl-carbinol. Enhances safety and purity for pharmaceutical intermediates. Reliable supply chain partner.
Patent CN103073399B reveals solvent-free hydrogenation for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN102381947B details a green 3-step synthesis for high-purity chiral 2,2'-dialkoxy-1,1'-binaphthyl, offering significant cost reduction and supply chain reliability.
Novel preparation method for Canagliflozin intermediates ensures high purity and yield. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Patent CN105712854B reveals efficient Ir-catalyzed biomass conversion. Achieve high purity and cost reduction in fine chemical manufacturing with scalable aqueous processes.
Discover a scalable synthesis route for chiral binaphthalene dicarboxylic acid via patent CN101781197A. Achieve >99% optical purity and significant cost reduction in pharma intermediate manufacturing.
Advanced patent CN104961675A enables safer isavuconazole intermediate production. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN104803829B reveals efficient asymmetric synthesis. Achieve high ee values and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Discover a novel synthesis method for indole-derived piperidines with >95% diastereoselectivity and 76% yield. Ideal for pharmaceutical R&D and cost-effective production of anti-cancer agents.